UBS Group’s NeOnc Technologies NTHI Stock Holding History
Bought
Maintained
Sold
Other funds holding NTHI
CCM
VCM
VFT
UBS Group's NTHI Position: Q1 2026 in Review
UBS Group reduced its NeOnc Technologies (NTHI) stake by 89% in Q1 2026, selling an estimated $20.2K and leaving 273 shares worth $1.91K. The position accounts for ﹤0.01% of the portfolio, ranked #9406.
UBS Group first reported a position in NTHI in Q2 2025 and has held it in 4 quarters since. The position peaked at $33.7K in Q2 2025. 27 funds tracked by Wall St. Rank hold NTHI as of Q1 2026.
- UBS Group held 273 shares of NeOnc Technologies worth $1.91K as of Q1 2026.
- UBS Group sold 2,227 NeOnc Technologies shares in Q1 2026, an estimated $20.2K.
- NeOnc Technologies made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9406 holding.
- UBS Group first reported a position in NeOnc Technologies in Q2 2025 and has held it in 4 quarters since.
- UBS Group's NeOnc Technologies position peaked at $33.7K in Q2 2025.
- 27 funds tracked by Wall St. Rank held NeOnc Technologies as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.